Recommended Citation
Chen I, Perkins SQ, Schwartz SE, and Leavitt D. Nephrolithiasis associated with embolization material, Lipiodol®, following embolization of large renal angiomyolipoma. Urol Case Rep 2022; 40:101910.
Document Type
Article
Publication Date
1-1-2022
Publication Title
Urol Case Rep
Abstract
Angiomyolipoma (AML) is a benign renal mass that can be treated with nephron sparing surgery or transarterial embolization. Embolization has been favored due to efficacy and safety profile. This case demonstrates a previously undocumented phenomenon of AML treated with transarterial embolization using Lipiodol® (Guerbet LLC, Princeton, NJ) resulting in nephrolithiasis and retention of Lipiodol® two years after original embolization. Although Lipiodol®-based embolization has not been shown to cause nephrolithiasis, it may have been the nidus for stone formation, and this is an important potential complication worthy of further study.
PubMed ID
34786344
Volume
40
First Page
101910
Last Page
101910
